Introduction and hypothesis In 2008 and 2011, the US Food and Drug Administration (FDA)
released notifications regarding vaginal mesh. In describing prolapse surgery trends over …

Objective Our objective was to quantitate the extent of complications and failure rate for
apical prolapse repair with transvaginal mesh (TVM) use versus sacrocolpopexy over a …

Introduction and hypothesis To assess trends in the surgical management of pelvic organ
prolapse (POP) amongst UK practitioners and changes in practice since a previous similar …

OBJECTIVE: Limited data exist on the rates of pelvic organ prolapse procedures utilizing
mesh. The objective of this study was to examine trends in vaginal mesh prolapse …

OBJECTIVE: To present the 3-year outcomes of a double-blind, multicenter, randomized trial
comparing vaginal prolapse repair with and without mesh. METHODS: This was a planned …

Introduction and hypothesis Few studies have compared the different approaches of mesh
surgery in patients with severe pelvic organ prolapse (POP). In addition to laparoscopic …

Introduction and hypothesis Women have a lifetime risk of undergoing pelvic organ prolapse
(POP) surgery of 11–19%. Traditional native tissue repairs are associated with reoperation …

Objective Use of vaginal meshes for treatment of pelvic organ prolapse (POP) remains
controversial. A trend toward abdominal approaches and the development of new meshes …

OBJECTIVE: To present 3-month outcomes of a double-blind, multicenter randomized
controlled trial comparing traditional vaginal prolapse surgery without mesh with vaginal …

Objective To investigate recent trends in mesh use for pelvic organ prolapse (POP)-related
reconstruction procedures. Materials and Methods Using the 2001-2011 5% Medicare …